BHCM
MYGN icon

Brevan Howard Capital Management’s Myriad Genetics MYGN Stock Holding History

Brevan Howard Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96K Buy
+21,333
New +$111K ﹤0.01% 2031
2025
Q4 		– Sell
-21,900
Closed -$158K – 2130
2025
Q3 		$158K Buy
+21,900
New +$130K ﹤0.01% 1802
2024
Q4 		– Sell
-16,965
Closed -$465K – 1310
2024
Q3 		$465K Buy
16,965
+2,349
+16% +$63.6K 0.02% 701
2024
Q2 		$358K Buy
+14,616
New +$321K 0.02% 718

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return